Receive our newsletter – data, insights and analysis delivered to you
  1. Market Data
November 16, 2011

US drug shortages limited to generic injectables

Prescription drug shortages in the US are primarily limited to generic injectables, but are increasing concern according to a new study produced by the IMS Institute for Healthcare Informatics.

By Liam Stoker

Prescription drug shortages in the US are primarily limited to generic injectables, but are increasing concern according to a new study produced by the IMS Institute for Healthcare Informatics.

The study calls for healthcare stakeholders to create an early warning system to prevent future shortages, minimising disruption to patient care.

The study has found that of the drug shortages, in excess of 80% are generic products and injectables, representing a small proportion of the complete medicine market.

They do, however, include a number of drugs deemed critical to the treatment of potentially life-threatening conditions including cancer, cardiovascular disease and central nervous system conditions.

Related Companies

Content from our partners
How Hengst helped to keep Germany’s charity “star singers” shining
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
Patient-centric pharma logistics: How CRYOPDP delivers hope worldwide

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU